Skip to Content

Rosiglitazone use while Breastfeeding

Drugs containing Rosiglitazone: Avandia, Avandamet, Avandaryl

Medically reviewed on Apr 2, 2018

Rosiglitazone Levels and Effects while Breastfeeding

Summary of Use during Lactation

No information is available on the clinical use of rosiglitazone during breastfeeding. Rosiglitazone is over 99% protein bound in plasma, so it is unlikely to pass into breastmilk in clinically important amounts. The manufacturer recommends avoiding breastfeeding during rosiglitazone use, so pioglitazone might be a better choice of the drugs in this class for nursing mothers.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

Acarbose, Glipizide, Glyburide, Insulin, Metformin, Miglitol

References

Rosiglitazone Identification

Substance Name

Rosiglitazone

CAS Registry Number

122320-73-4

Drug Class

Hypoglycemic Agents

Thiazolidinediones

Administrative Information

LactMed Record Number

241

Disclaimer

Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide